Briacell Therapeutics Corp. Common Shares vs. Johnson & Johnson
Briacell Therapeutics Corp. Common Shares and Johnson & Johnson are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| BCTX | JNJ | |
|---|---|---|
| Market Cap | $30.45 million | $620.77 billion |
| Revenue (TTM) | — | — |
| Net Income (TTM) | $-30,976,383 | — |
JNJ leads on 1 of 1 size & scale factors.
Valuation
| BCTX | JNJ | |
|---|---|---|
| Price / Book | 1.30 | — |
BCTX and JNJ split the valuation factors evenly.
Profitability
| BCTX | JNJ | |
|---|---|---|
| Return on Equity | -132.33% | — |
BCTX and JNJ split the profitability factors evenly.
Risk & Sentiment
| BCTX | JNJ | |
|---|---|---|
| Short Interest | 0.29% | 0.67% |
BCTX leads on 1 of 1 risk & sentiment factors.
Dig deeper: BCTX overview, BCTX financials, JNJ overview, JNJ financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.